Literature DB >> 19706920

Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya.

Ann M Moormann1, Peter Odada Sumba, Daniel J Tisch, Paula Embury, Charles H King, James W Kazura, Chandy C John.   

Abstract

Long-term planning to prevent malaria epidemics requires in-depth understanding of immunity to Plasmodium falciparum in areas of unstable transmission. Cytokine responses to immunodominant epitope peptides from liver stage antigen 1 (LSA-1) and thrombospondin-related adhesive protein (TRAP) were evaluated over a nine-month interval in adults and children in Kenya from a malaria epidemic-prone highland area after several years of low transmission. The proportion and magnitude of interferon-gamma ELISPOT responses and the proportion of interleukin-10 responders to LSA-1 and TRAP peptides tended to be higher in adults than children. Frequencies of interferon-gamma responders to these peptides were similar at the two time points, but responses were not consistently generated by the same persons. These results suggest that T cell memory to pre-erythrocytic stage malaria antigens is maintained but may be unavailable for consistent detection in peripheral blood, and that these antigens induce both pro-inflammatory and anti-inflammatory cytokine responses in this population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706920      PMCID: PMC3634720     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine.

Authors:  J D Kurtis; M R Hollingdale; A J Luty; D E Lanar; U Krzych; P E Duffy
Journal:  Trends Parasitol       Date:  2001-05

2.  Low prevalence of Plasmodium falciparum infection among asymptomatic individuals in a highland area of Kenya.

Authors:  Chandy C John; Marilyn M McHugh; Ann M Moormann; Peter O Sumba; Ayub V Ofulla
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-10       Impact factor: 2.184

3.  Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen-1 and thrombospondin-related adhesive protein in residents of a malaria holoendemic area.

Authors:  Ann M Moormann; Chandy C John; Peter Odada Sumba; Daniel Tisch; Paula Embury; James W Kazura
Journal:  Am J Trop Med Hyg       Date:  2006-04       Impact factor: 2.345

Review 4.  T-cell quality in memory and protection: implications for vaccine design.

Authors:  Robert A Seder; Patricia A Darrah; Mario Roederer
Journal:  Nat Rev Immunol       Date:  2008-03-07       Impact factor: 53.106

Review 5.  Plasmodium falciparum malaria vaccines in development.

Authors:  Johan Vekemans; W Ripley Ballou
Journal:  Expert Rev Vaccines       Date:  2008-03       Impact factor: 5.217

Review 6.  High road, low road? Choices and challenges on the pathway to a malaria vaccine.

Authors:  T Richie
Journal:  Parasitology       Date:  2006       Impact factor: 3.234

Review 7.  The uncertain burden of Plasmodium falciparum epidemics in Africa.

Authors:  Jonathan Cox; Simon I Hay; Tarekegn A Abeku; Francesco Checchi; Robert W Snow
Journal:  Trends Parasitol       Date:  2007-02-15

8.  Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya.

Authors:  C C John; P O Sumba; J H Ouma; B L Nahlen; C L King; J W Kazura
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

9.  Fine specificity of neonatal lymphocytes to an abundant malaria blood-stage antigen: epitope mapping of Plasmodium falciparum MSP1(33).

Authors:  Indu Malhotra; Alex N Wamachi; Peter L Mungai; Elton Mzungu; Davy Koech; Eric Muchiri; Ann M Moormann; Christopher L King
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

10.  HLA class I supertypes: a revised and updated classification.

Authors:  John Sidney; Bjoern Peters; Nicole Frahm; Christian Brander; Alessandro Sette
Journal:  BMC Immunol       Date:  2008-01-22       Impact factor: 3.615

View more
  11 in total

1.  Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.

Authors:  Lyticia A Ochola; Cyrus Ayieko; Lily Kisia; Ng'wena G Magak; Estela Shabani; Collins Ouma; Chandy C John
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

2.  Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.

Authors:  Michele D Spring; Kiprotich Chelimo; Daniel J Tisch; Peter Odada Sumba; Rosemary Rochford; Carole A Long; James W Kazura; Ann M Moormann
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

3.  Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity.

Authors:  Jiraprapa Wipasa; Lucy Okell; Supachai Sakkhachornphop; Chaisuree Suphavilai; Kriangkrai Chawansuntati; Witaya Liewsaree; Julius C R Hafalla; Eleanor M Riley
Journal:  PLoS Pathog       Date:  2011-02-10       Impact factor: 6.823

4.  Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.

Authors:  Daniel Dodoo; Michael R Hollingdale; Dorothy Anum; Kwadwo A Koram; Ben Gyan; Bartholomew D Akanmori; Josephine Ocran; Susan Adu-Amankwah; Harini Geneshan; Esteban Abot; Jennylyn Legano; Glenna Banania; Renato Sayo; Donald Brambilla; Sanjai Kumar; Denise L Doolan; William O Rogers; Judith Epstein; Thomas L Richie; Martha Sedegah
Journal:  Malar J       Date:  2011-06-20       Impact factor: 2.979

5.  Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans.

Authors:  Anne C Teirlinck; Matthew B B McCall; Meta Roestenberg; Anja Scholzen; Rob Woestenenk; Quirijn de Mast; Andre J A M van der Ven; Cornelus C Hermsen; Adrian J F Luty; Robert W Sauerwein
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

6.  Recurrent Plasmodium falciparum malaria infections in Kenyan children diminish T-cell immunity to Epstein Barr virus lytic but not latent antigens.

Authors:  Cynthia J Snider; Stephen R Cole; Kiprotich Chelimo; Peter Odada Sumba; Pia D M Macdonald; Chandy C John; Steven R Meshnick; Ann M Moormann
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

Review 7.  Plasmodium cellular effector mechanisms and the hepatic microenvironment.

Authors:  Ute Frevert; Urszula Krzych
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

8.  The Plasmodium falciparum Antigen MB2 Induces Interferon-γ and Interleukin-10 Responses in Adults in Malaria Endemic Areas of Western Kenya.

Authors:  Lyticia A Ochola; Gideon M Ng'wena; Gregory S Noland; Bartholomew N Ondigo; George Ayodo; Chandy C John
Journal:  J Glob Infect Dis       Date:  2013-10

9.  Interferon-γ responses to Plasmodium falciparum vaccine candidate antigens decrease in the absence of malaria transmission.

Authors:  Cyrus Ayieko; Bilha S Ogola; Lyticia Ochola; Gideon A M Ngwena; George Ayodo; James S Hodges; Gregory S Noland; Chandy C John
Journal:  PeerJ       Date:  2017-01-10       Impact factor: 2.984

Review 10.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.